References
1. Davies M.J., McKenna W.J. Hypertrophic cardiomyopathy – pathology and pathogenesis. Histopathology. 1995; 26 (6): 493–500. DOI: https://doi.org/10.1111/j.1365-2559.1995.tb00267.x
2. Hughes S.E. The pathology of hypertrophic cardiomyopathy. Histopathology. 2004; 44 (5): 412–27. DOI: https://doi.org/10.1111/j.1365-2559.2004.01835.x
3. Ommen S.R., Mital S., Burke M.A., et al. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2020; 76 (25): e159–240. DOI: https://doi.org/10.1161/CIR.0000000000000938
4. McLeod C.J., Bos J.M., Theis J.L., et al. Histologic characterization of hypertrophic cardiomyopathy with and without myofilament mutations. Am Heart J. 2009; 158 (5): 799–805. DOI: https://doi.org/10.1016/j.ahj.2009.09.006
5. Cui H., Schaff H.V., Lentz Carvalho J., et al. Myocardial histopathology in patients with obstructive hypertrophic cardio-
myopathy. J Am Coll Cardiol. 2021; 77 (17): 2159–70. DOI: https://doi.org/10.1016/j.jacc.2021.03.008
6. Mershina E.A., Sinitsyn V.E., Larina O.M. Magnetic resonance imaging of the heart in diagnosis of hypertrophic cardiomyo-
pathy and risk stratification of sudden cardiac death. Clinical and Experimental Surgery. Petrovsky Journal. 2019; 7 (3): 70–8. DOI: https://doi.org/10.24411/2308-1198-2019-13008 (in Russian)
7. Kubo T., Gimeno J. R., Bahl A., et al. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype. J Am Coll Cardiol. 2007; 49 (25): 2419–26. DOI: https://doi.org/10.1016/j.jacc.2007.02.061
8. Nishimura R.A., Schaff H.V. Septal myectomy for patients with hypertrophic cardiomyopathy: a new paradigm. J Thorac Cardiovasc Surg. 2016; 151 (2): 303–4. DOI: https://doi.org/10.1016/j.jtcvs.2015.09.068
9. Takayama H., Chung W.K., Maurer M.S., et al. Hypertrophic cardiomyopathy: new approaches and a time to reappraise older approaches. J Thorac Cardiovasc Surg. 2016; 152 (4): 983–8. DOI: https://doi.org/10.1016/j.jtcvs.2016.06.034
10. Bogachev-Prokof’ev A.V., Zheleznev S.M., Fomenko M.S.,
et al. The first experience of extended myoectomy in surgical treatment of obstructive hypertrophic cardiomyopathy: immediate and intermediate results. Patologiya krovoobrashcheniya i kardiokhirurgiya [Pathology of Blood Circulation and Cardiac Surgery]. 2015; 19 (2): 20–5. (in Russian)
11. Dzemeshkevich S.L., Motreva A.P., Kalmykova O.V., et al. Hypertrophic cardiomyopathy in youth: phenotype, genotype, and treatment approaches. Clinical and Experimental Surgery. Petrovsky Journal. 2019; 7 (3): 54–62. DOI: https://doi.org/10.24411/2308-1198-2019-13006 (in Russian)
12. Dzemeshkevich S.L., Motreva A.P., Mart’yanova Y.B., et al. Combined operations for hypertrophic cardiomyopathy. Clinical and Experimental Surgery. Petrovsky Journal. 2022; 10 (3): 59–63. DOI: https://doi.org/10.33029/2308-1198-2022-10-3-59-63 (in Russian)
13. Dzhordzhikiya R.K., Volodyukhin M.Yu., Safarova D.F., et al. Comparative evaluation of methods of surgical treatment of obstructive hypertrophic cardiomyopathy. Clinical and Experimental Surgery. Petrovsky Journal. 2020; 8 (3): 51–8. DOI: https://doi.org/10.33029/2308-1198-2020-8-3-51-58 (in Russian)
14. Rosca M.G., Tandler B., Hoppel C.L. Mitochondria in cardiac hypertrophy and heart failure. J Mol Cell Cardiol. 2013; 55: 31–41. DOI: https://doi.org/10.1016/j.yjmcc.2012.09.002
15. Ranjbarvaziri S., Kooiker K.B., Ellenbergeret M., et al. Altered cardiac energetics and mitochondrial dysfunction in hypertrophic cardiomyopathy. Circulation. 2021; 144 (21): 1714–31. DOI: https://doi.org/10.1161/CIRCULATIONAHA.121.053575
16. Braunwald E. Mitochondrial cardiomyopathy: a fertile field for research. Eur Heart J. 2023; 44 (26): 2361–2. DOI: https://doi.org/10.1093/eurheartj/ehad177
17. Obayashi T., Hattori K., Sugiyama S., et al. Point mutations in mitochondrial DNA in patients with hypertrophic cardiomyopathy. Am Heart J. 1992; 124 (5): 1263–9. DOI: https://doi.org/10.1016/0002-8703(92)90410-W
18. Broeke J., Pérez J.M.M., Pascau J. Image Processing with ImageJ. Birmingham: Packt Publishing, 2015: 256 p.
19. Grishaev S.L. Electrical instability of myocardium: cause, diagnosis, treatment. Saint Petersburg: Vit-Print, 2011: 128 p. (in Russian)
20. Kivva V.N., Abramova T.N. Pathogenesis of heart failure. Astrakhanskiy meditsinskiy zhurnal [Astrakhan Medical Journal]. 2009; 4 (1): 73–81. (in Russian)
21. Kirkina N.Y., Savkina A.N. Hypertrophic cardiomiopathy, a modern view on ethiology and treatment of this pathology. Klinicheskaya meditsina i farmakologiya [Clinical Medicine and Pharmacology]. 2017; 3 (4): 2–10. (in Russian)
22. Novakovskaya S.A., Komissarova S.M., Archakova L.I. Ultrastructural basis of remodeling of vessels of the myocardial microcirculatory channel in hypertrophic cardiomyopathy. In: Endothelial Dysfunction: Experimental and Clinical Studies. 2018: 91–4. (in Russian)
23. Johansson B., Mörner S., Waldenström A., et al. Myocardial capillary supply is limited in hypertrophic cardiomyopathy:
a morphological analysis. Int J Cardiol. 2008; 126 (2): 252–7. DOI: https://doi.org/10.1016/j.ijcard.2007.04.003
24. Devin A., Rigoulet M. Mechanisms of mitochondrial response to variations in energy demand in eukaryotic cells. Am J Physiol Cell Physiol. 2007; 292 (1): C52–8. DOI: https://doi.org/10.1152/ajpcell.00208.2006
25. Baker N., Patel J., Khacho M. Linking mitochondrial dynamics, cristae remodeling and supercomplex formation: how mitochondrial structure can regulate bioenergetics. Mitochondrion. 2019; 49: 259–68. DOI: https://doi.org/10.1016/j.mito.2019.06.003
26. Lukyanova L., Germanova E., Khmil N., et al. Signaling role of mitochondrial enzymes and ultrastructure in the formation of molecular mechanisms of adaptation to hypoxia. Int J Mol Sci. 2021; 22 (16): 8636. DOI: https://doi.org/10.3390/ijms22168636
27. Sarkisov D.S. Regeneration and its clinical significance. Moscow: Meditsina, 1970: 284 p. (in Russian)
28. Structural bases of adaptation and compensation of disturbed functions: Manual. In: D.S. Sarkisov (ed). Moscow: Meditsina, 1987: 445 p. (in Russian)
29. Cheville N.F. Ultrastructural Pathology: the Comparative Cellular Basis of Disease. John Wiley & Sons, 2009: 977 p.
30. Sparrow A.J., Sievert K., Patel S., et al. Measurement of myofilament-localized calcium dynamics in adult cardiomyocytes and the effect of hypertrophic cardiomyopathy mutations. Circ Res. 2019; 124 (8): 1228–39. DOI: https://doi.org/10.1161/CIRCRESAHA.118.314600
31. Terman A., Kurz T., Gustafsson B., et al. The involvement of lysosomes in myocardial aging and disease. Curr Cardiol Rev. 2008; 4 (2): 107–15. DOI: https://doi.org/10.2174/157340308784245801
32. Yamamoto S., Sawada K. I., Shimomura H., et al. On the nature of cell death during remodeling of hypertrophied human myocardium. J Mol Cell Cardiol. 2000; 32 (1): 161–75. DOI: https://doi.org/10.1006/jmcc.1999.1064